Automated live cell high-content screening platform
CelTor Biosystems required an automated in-house test platform for high-content screening of live cells.
The system would be used in a range of drug discovery process steps from target validation to lead optimization. The complex workstation needed to combine high-performance fluorescent imaging with microfluidics technology for automation of cell-based assays.
Cellaxess® Elektra fully automated workstation for transfection of biologically relevant cell types
Cellectricon was looking to expand the market of their Cellaxess® in-plate electroporation technology by developing an instrument for automated high-throughput electroporation of adherent cells for use in drug discovery screening.
CAR-T manufacturing automation
A common challenge in the emerging cell and gene therapy industry is translating manual production methods to clinical and commercial-scale manufacturing. Recently, a clinical-stage biopharmaceutical company was looking to commercialize an autologous Dendritic cell therapy, an immunotherapeutic approach for treating and preventing cancers and autoimmune diseases.
RoboSep™ fully automated magnetic cell separator
The RoboSep® is the world’s first fully automated cell separation system that allows true walk-away automation. We developed this instrument and its disposables from idea to transfer-to-manufacture in 14 months, with the first Beta prototype delivered in 12 months.
Organovo turned science fiction into science fact
“Imagine being able to print human tissues on demand.”
This was the inspiration for start-up company Organovo as they set out to build the world’s first production 3D bioprinter.
For decades, the goal of tissue engineers has been to advance beyond simple two-dimensional cell cultures to creating three-dimensional organs. Organovo had a vision to produce a 3D bioprinter that would make this dream a reality, providing surgeons with tissue on demand and helping solve the global shortage of human organs.